| Title: |
The efficacy and safety of levilimab in severely ill COVID-19 patients not requiring mechanical ventilation: results of a multicenter randomized double-blind placebo-controlled phase III CORONA clinical study |
| Authors: |
Lomakin, Nikita V.Aff1; Bakirov, Bulat A.Aff2; Protsenko, Denis N.Aff3; Mazurov, Vadim I.Aff4; Musaev, Gaziyavdibir H.Aff5; Moiseeva, Olga M.Aff6; Pasechnik, Elena S.Aff7; Popov, Vladimir V.Aff8; Smolyarchuk, Elena A.Aff9; Gordeev, Ivan G.Aff10; Gilyarov, Mikhail YuAff11; Fomina, Darya S.Aff12, Aff13; Seleznev, Anton I.Aff14; Linkova, Yulia N.Aff14; Dokukina, Ekaterina A.Aff14; Eremeeva, Anna V.Aff14; Pukhtinskaia, Polina S.Aff14, IDs00011021015075_cor17; Morozova, Maria A.Aff14; Zinkina-Orikhan, Arina V.Aff14; Lutckii, Anton A.Aff14 |
| Source: |
Inflammation Research: Official Journal of: The International Association of Inflammation Societies + The European Histamine Research Society. 70(1012):1233-1246 |
| Database: |
Springer Nature Journals |